Study of bb2121 in Multiple Myeloma
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02658929 |
Recruitment Status :
Completed
First Posted : January 20, 2016
Last Update Posted : January 23, 2023
|
Sponsor:
Celgene
Collaborator:
bluebird bio
Information provided by (Responsible Party):
Celgene
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | July 22, 2019 |
Actual Study Completion Date : | September 22, 2022 |